The LaLiMo trial: Lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy - An open-label, prospective, randomised controlled multicenter study

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 83, Issue 11, 2012, Pages 1093-1098

  Rosenow, Felix ^a   Schade Brittinger, Carmen ^b   Burchardi, Nicole ^b   Bauer, Sebastian ^a   Klein, Karl Martin ^a   Weber, Yvonne ^c,d   Lerche, Holger ^c,d   Evers, Stefan ^e   Kovac, Stjepana ^e   Hallmeyer Elgner, Susanne ^f   Winkler, Götz ^g   Springub, Joachim ^h   Niedhammer, Mathias ⁱ   Roth, Erhard ^j   Eisensehr, Ilonka ^k   Berrouschot, Jörg ^l   Arnold, Stephan ^m   Schröder, Michael ^k   Beige, Anja ^k   Oertel, Wolfgang H ^a   Strzelczyk, Adam ^a   Haag, Anja ^a   Reif, Philipp S ^a   Hamer, Hajo M ^a   more..

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^e UNIVERSITY OF MÜNSTER   (Germany)

^f DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^g Leopoldina Hospital   (Germany)

^h Private Neurological Practice   (Germany)

ⁱ Private Neurological Practice   (Germany)

^j Private Neurological Practice   (Germany)

^k Private Neurological Practice   (Germany)

^l District Hospital Altenburg   (Germany)

^m UNIVERSITY OF REGENSBURG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ETIRACETAM; LAMOTRIGINE;

ADOLESCENT; ADULT; ADVERSE OUTCOME; AGGRESSION; ARTICLE; ASTHENIA; CHILD; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; FATIGUE; FEMALE; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NAUSEA; OPEN STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SIDE EFFECT; SLEEP DISORDER; TREMOR; UPPER RESPIRATORY TRACT INFECTION; VERTIGO;

ADOLESCENT; ADULT; ANTICONVULSANTS; CHILD; EARLY DIAGNOSIS; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; PIRACETAM; QUALITY OF LIFE; TRIAZINES;

EID: 85027926729     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2011-301999     Document Type: Article

References (30)

1. Forsgren L, Beghi E, Oun A, et al. The epidemiology of epilepsy in Europe - a systematic review. Eur J Neurol 2005;12:245-53. (Pubitemid 40477131)
2. King MA, Newton MR, Jackson GD, et al. Epileptology of the first-seizure presentation: a clinical, electroencephalographic, and magnetic resonance imaging study of 300 consecutive patients. Lancet 1998;352:1007-11. (Pubitemid 28438571)
3. Anon. Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy. Epilepsia 1998;39:799-803.
4. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000;342:314-19. (Pubitemid 30075244)
5. Anon. Prognostic index for recurrence of seizures after remission of epilepsy. Medical Research Council Antiepileptic Drug Withdrawal Study Group. BMJ 1993;306:1374-8.
6. Specchio LM, Tramacere L, La Neve A, et al. Discontinuing antiepileptic drugs in patients who are seizure free on monotherapy. J Neurol Neurosurg Psychiatry 2002;72:22-5. (Pubitemid 34073090)
7. Marson AG, Al-Kharusi AM, Alwaidh M, et al; SANAD Study group. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007;369:1000-15. (Pubitemid 46436124)
8. Marson AG, Al-Kharusi AM, Alwaidh M, et al; SANAD Study group. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 2007;369:1016-26. (Pubitemid 46436125)
9. Brodie MJ, Perucca E, Ryvlin P, et al Levetiracetam Monotherapy Study Group. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology 2007;68:402-8. (Pubitemid 46208740)
10. Pohlmann-Eden B, van Paesschen W, Hallström Y, et al. The KOMET study: an open-label, randomized, parallel-group trial comparing the efficacy and safety of levetiracetam with sodium valproate and carbamazepine as monotherapy in subjects with newly diagnosed epilepsy. Epilepsia 2008;49(Suppl 7):448-9.
11. Drazkowski J. An overview of epilepsy and driving. Epilepsia 2007;48(Suppl 9):10-12. (Pubitemid 350198219)
12. Smeets VM, van Lierop BA, Vanhoutvin JP, et al. Epilepsy and employment: literature review. Epilepsy Behav 2007;10:354-62. (Pubitemid 46567775)
13. Strzelczyk A, Reese JP, Dodel R, et al. Cost of epilepsy: a systematic review. Pharmacoeconomics 2008;26:463-76. (Pubitemid 351704857)
14. Haut S, O'Dell C, Shinnar S. Risk factors for developing epilepsy after a first unprovoked seizure. In: Ryvlin P, ed. From First Unprovoked Seizure to Newly Diagnosed Epilepsy. Montrouge, France: John Libbey Eurotext, 2007:37-48.
15. Kim LG, Johnson TL, Marson AG, et al. Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the MESS trial. Lancet Neurol 2006;5:317-22.
16. Fisher RS, van Emde Boas W, Blume W, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005;46:470-2. (Pubitemid 40470667)
17. Cramer JA, Arrigo C, Van Hammee G, et al. Comparison between the QOLIE-31 and derived QOLIE-10 in a clinical trial of levetiracetam. Epilepsy Res 2000;41:29-38. (Pubitemid 30621399)
18. Cramer JA, Perrine K, Devinsky O, et al. A brief questionnaire to screen for quality of life in epilepsy: the QOLIE-10. Epilepsia 1996;37:577-82. (Pubitemid 26169193)
19. Brodie MJ, Chadwick DW, Anhut H, et al. Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy. Epilepsia 2002;43:993-1000. (Pubitemid 35006474)
20. Brodie MJ, Overstall PW, Giorgi L. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. Epilepsy Res 1999;37:81-7. (Pubitemid 29413167)
21. Brodie MJ, Richens A, Yuen AW. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Lancet 1995;345:476-9.
22. Chaisewikul R, Privitera MD, Hutton JL, et al. Levetiracetam add-on for drug-resistant localization related (partial) epilepsy. Cochrane Database Syst Rev 2001;(1):CD001901.
23. Gamble CL, Williamson PR, Marson AG. Lamotrigine versus carbamazepine monotherapy for epilepsy. Cochrane Database Syst Rev 2006;(1):CD001031.
24. Labiner DM, Ettinger AB, Fakhoury TA, et al. Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy. Epilepsia 2009;50:434-42.
25. Reunanen M, Dam M, Yuen AW. A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy. Epilepsy Res 1996;23:149-55. (Pubitemid 26124783)
26. Steiner TJ, Dellaportas CI, Findley LJ, et al. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin. Epilepsia 1999;40:601-7. (Pubitemid 29207324)
27. Guekht AB, Mitrokhina TV, Lebedeva AV, et al. Factors influencing on quality of life in people with epilepsy. Seizure 2007;16:128-33. (Pubitemid 46222211)
28. Josephson CB, Leach JP, Duncan R, et al Scottish Audit of Intracranial Vascular Malformations (SAIVMs) steering committee and collaborators. Seizure risk from cavernous or arteriovenous malformations: prospective population-based study. Neurology 2011;76:1548-54.
29. Shinnar S, Berg AT, Moshe SL, et al. The risk of seizure recurrence after a first unprovoked afebrile seizure in childhood: an extended follow-up. Pediatrics 1996;98:216-25. (Pubitemid 26262133)
30. Shinnar S, Kang H, Berg AT, et al. EEG abnormalities in children with a first unprovoked seizure. Epilepsia 1994;35:471-6. (Pubitemid 24217747)